Abstract
Curcumin is a kind of polyphenol substance extracted from the rhizome of Curcuma longa. Because of its good biological activity and pharmacological effects, it has been used in anti-tumor research. The aim of this study was to investigate the anti-cancer mechanism of curcumin on laryngeal squamous cell carcinoma (LSCC). Quantitative real-time polymerase chain reaction (qRT-PCR) was performed to check the expression level of transcription factor E2F1 (E2F1) and filamin A (FLNA) mRNA. E2F1 and FLNA protein and proliferation-associated protein were detected through western blot. Cell viability was showed by MTT assay, and flow cytometry was used to exhibit cell cycle distribution and cell apoptosis. Tube formation assay was used to detect the angiogenesis ability of cells. Transwell was used as a method to observe cell migration and invasion. The online website JASPAR predicted the binding site of E2F1 and FLNA promoter, and chromatin immunoprecipitation (ChIP) and dual-luciferase report experiment verified the combination. Curcumin treatment made LSCC cells viability reduce, cell cycle retardant, angiogenesis decrease, metastasis inhibition and apoptosis increase. And curcumin treatment could downregulate the expression of E2F1, and E2F1 overexpression would reverse the influence of curcumin treatment in LSCC cells. Moreover, E2F1 could bind to FLAN promoter and promote FLNA expression. The expression level of FLNA was higher in LSCC tissue and cells compared with normal tissue and cells. E2F1 knockdown inhibited malignant phenotype of LSCC cells, which would be reversed by FLNA addition. In addition, FLNA had high level in LSCC tissue and cells. Curcumin regulated FLNA expression via inhibiting E2F1. Finally, in vivo assay showed that curcumin inhibition restrained LSCC tumor formation. Curcumin downregulated FLNA expression through inhibiting E2F1, thereby suppressing the malignant phenotype and angiogenesis of LSCC cells, which was a new regulatory pathway in LSCC.
Similar content being viewed by others
Data availability
No datasets were generated or analysed during the current study.
References
Ahmadi N, Ahmadi N, Chan MV, Huo YR, Sritharan N, Chin R (2018) Laryngeal squamous cell carcinoma survival in the context of human papillomavirus: a systematic review and meta-analysis. Cureus 10(2):e2234
Carolina Alves R, Perosa Fernandes R, Fonseca-Santos B, Damiani Victorelli F, Chorilli M (2019) A critical review of the properties and analytical methods for the determination of curcumin in biological and pharmaceutical matrices. Crit Rev Anal Chem 49(2):138–149
Cheng M, Jiang Y, Yang H, Zhao D, Li L, Liu X (2020) FLNA promotes chemoresistance of colorectal cancer through inducing epithelial-mesenchymal transition and smad2 signaling pathway. Am J Cancer Res 10(2):403–423
Deng XZ, Geng SS, Luo M, Chai JJ, Xu Y, Chen CL, Qiu L, Ke Q, Duan QW, Song SM, Shen L, Luo ZG (2020) Curcumin potentiates laryngeal squamous carcinoma radiosensitivity via NF-ΚB inhibition by suppressing IKKγ expression. J Recept Signal Transduct Res 40(6):541–549
Hartwig JH, Stossel TP (1975) Isolation and properties of actin, myosin, and a new actinbinding protein in rabbit alveolar macrophages. J Biol Chem 250(14):5696–5705
Huangfu H, Pan H, Wang B, Wen S, Han R, Li L (2016) Association between UGT1A1 polymorphism and risk of laryngeal squamous cell carcinoma. Int J Environ Res Public Health 13(1):112
Joshi P, Verma K, Kumar Semwal D, Dwivedi J, Sharma S (2023) Mechanism insights of curcumin and its analogues in cancer: an update. Phytother Res 37(12):5435–5463
Kotha RR, Luthria DL (2019) Curcumin: biological, pharmaceutical, nutraceutical, and analytical aspects. Molecules 24(16):2930
Lee YT, Tan YJ, Oon CE (2018) Molecular targeted therapy: treating cancer with specificity. Eur J Pharmacol 834:188–196
Leiherer A, Mündlein A, Drexel H (2013) Phytochemicals and their impact on adipose tissue inflammation and diabetes. Vascul Pharmacol 58(1–2):3–20
Li P, Lin XJ, Yang Y, Yang AK, Di JM, Jiang QW, Huang JR, Yuan ML, Xing ZH, Wei MN, Li Y, Yuan XH, Shi Z, Liu H, Ye J (2019a) Reciprocal regulation of miR-1205 and E2F1 modulates progression of laryngeal squamous cell carcinoma. Cell Death Dis 10(12):916
Li S, Xu HX, Wu CT, Wang WQ, Jin W, Gao HL, Li H, Zhang SR, Xu JZ, Qi ZH et al (2019b) Angiogenesis in pancreatic cancer: current research status and clinical implications. Angiogenesis 22(1):15–36
Lin X, Han T, Xia Q, Cui J, Zhuo M, Liang Y, Su W, Wang L, Wang L, Liu Z, Xiao X (2021) CHPF promotes gastric cancer tumorigenesis through the activation of E2F1. Cell Death Dis 12(10):876
Liu LD, Pang YX, Zhao XR, Li R, Jin CJ, Xue J, Dong RY, Liu PS (2019) Curcumin induces apoptotic cell death and protective autophagy by inhibiting AKT/mTOR/p70S6K pathway in human ovarian cancer cells. Arch Gynecol Obstet 299(6):1627–1639
Ludwig ML, Birkeland AC, Hoesli R, Swiecicki P, Spector ME, Brenner JC (2016) Changing the paradigm: the potential for targeted therapy in laryngeal squamous cell carcinoma. Cancer Biol Med 13(1):87–100
Luo J, Wu J, Lv K, Li K, Wu J, Wen Y, Li X, Tang H, Jiang A, Wang Z et al (2016) Analysis of postsurgical health-related quality of life and quality of voice of patients with laryngeal carcinoma. Medicine (Baltimore) 95(1):e2363
Ma J, He Z, Zhang H, Zhang W, Gao S, Ni X (2021) SEC61G promotes breast cancer development and metastasis via modulating glycolysis and is transcriptionally regulated by E2F1. Cell Death Dis 12(6):550
Majidpoor J, Mortezaee K (2021) Angiogenesis as a hallmark of solid tumors - clinical perspectives. Cell Oncol (Dordr) 44(4):715–737
Nakamura F, Stossel TP, Hartwig JH (2011) The filamins: organizers of cell structure and function. Cell Adh Migr 5(2):160–169
Ojo OA, Adeyemo TR, Rotimi D, Batiha GE, Mostafa-Hedeab G, Iyobhebhe ME, Elebiyo TC, Atunwa B, Ojo AB, Lima CMG, Conte-Junior CA (2022) Anticancer properties of curcumin against colorectal cancer: a review. Front Oncol 22(12):881641
Panahi Y, Saberi-Karimian M, Valizadeh O, Behnam B, Saadat A, Jamialahmadi T, Majeed M, Sahebkar A (2021) Effects of curcuminoids on systemic inflammation and quality of life in patients with colorectal cancer undergoing chemotherapy: a randomized controlled trial. Adv Exp Med Biol 1328:1–9
Prasad S, Gupta SC, Tyagi AK, Aggarwal BB (2014) Curcumin, a component of golden spice: from bedside to bench and back. Biotechnol Adv 32(6):1053–1064
Skora T, Nowak-Sadzikowska J, Mucha-Malecka A, Szyszka-Charewicz B, Jakubowicz J, Glinski B (2015) Postoperative irradiation in patients with pT3-4N0 laryngeal cancer: results and prognostic factors. Eur Arch Otorhinolaryngol 272(3):673–679
Steuer CE, El-Deiry M, Parks JR, Higgins KA, Saba NF (2017) An update on larynx cancer. CA Cancer J Clin 67(1):31–50
Tseng Y, An KM, Esue O, Wirtz D (2004) The bimodal role of filamin in controlling the architecture and mechanics of F-actin networks. J Biol Chem 279(3):1819–1826
Wang JX, Liu Y, Jia XJ, Liu SX, Dong JH, Ren XM, Xu O, Zhang HZ, Duan HJ, Shan CG (2019) Upregulation of circFLNA contributes to laryngeal squamous cell carcinoma migration by circFLNA-miR-486-3p-FLNA axis. Cancer Cell Int 19:196
Wang S, Wu W, Liu Y, Xing E, Jiao J, Li L, Li J, Wang D (2023) Curcumin induces apoptosis by suppressing XRCC4 expression in hepatocellular carcinoma. Nutr Cancer 75(10):1958–1967
Xi G, Dong Q, Yang B, Jiao D, Khan S (2023) Curcumin’s dose-dependent attenuation of gastric cancer cell progression via the PI3K pathway blockade. Dose Response 21(4):15593258231203584
Xu Y, Bismar TA, Su J, Xu B, Kristiansen G, Varga Z, Teng L, Ingber DE, Mammoto A, Kumar R et al (2010) Filamin A regulates focal adhesion disassembly and suppresses breast cancer cell migration and invasion. J Exp Med 207(11):2421–2437
Yen HY, Tsao CW, Lin YW, Kuo CC, Tsao CH, Liu CY (2019) Regulation of carcinogenesis and modulation through Wnt/β-catenin signaling by curcumin in an ovarian cancer cell line. Sci Rep 9(1):17267
Zhang K, Zhu T, Gao D, Zhang Y, Zhao Q, Liu S, Su T, Bernier M, Zhao R (2014) Filamin A expression correlates with proliferation and invasive properties of human metastatic melanoma tumors: implications for survival in patients. J Cancer Res Clin Oncol 140(11):1913–1926
Zhao L et al (2022) E2F1-induced FTH1P3 promoted cell viability and glycolysis through miR-377–3p/LDHA axis in laryngeal squamous cell carcinoma. Cancer Biother Radiopharm 37(4):276–286
Zhu X, Zhu R (2018) Curcumin suppresses the progression of laryngeal squamous cell carcinoma through the upregulation of miR-145 and inhibition of the PI3K/Akt/mTOR pathway. Onco Targets Ther 11:3521–3531
Author information
Authors and Affiliations
Contributions
Yuanchun Xie and Jingjing Qi designed and performed the research; Ju Liu analyzed the data; Yuanchun Xie and Jingjing Qi wrote the manuscript. All authors read and approved the final manuscript. The authors declare that all data were generated in-house and that no paper mill was used.
Corresponding authors
Ethics declarations
Ethics approval and consent to participate
Written informed consents were obtained from all participants and this study was permitted by the Ethics Committee of Jingmen No.2 People’s Hospital.
Consent for publication
Not applicable.
Competing interests
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Xie, Y., Qi, J. & Liu, J. Curcumin suppresses the malignant phenotype of laryngeal squamous cell carcinoma through downregulating E2F1 to inhibit FLNA. Naunyn-Schmiedeberg's Arch Pharmacol (2024). https://doi.org/10.1007/s00210-024-03059-x
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00210-024-03059-x